BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ning G, Huang YL, Zhen LM, Xu WX, Li XJ, Wu LN, Liu Y, Xie C, Peng L. Prognostic Value of Complement Component 2 and Its Correlation with Immune Infiltrates in Hepatocellular Carcinoma. Biomed Res Int 2020;2020:3765937. [PMID: 32626741 DOI: 10.1155/2020/3765937] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Xiao Z, Yeung CLS, Yam JWP, Mao X. An update on the role of complement in hepatocellular carcinoma. Front Immunol 2022;13:1007382. [DOI: 10.3389/fimmu.2022.1007382] [Reference Citation Analysis]
2 Yuan M, Liu L, Wang C, Zhang Y, Zhang J. The Complement System: A Potential Therapeutic Target in Liver Cancer. Life (Basel) 2022;12:1532. [PMID: 36294966 DOI: 10.3390/life12101532] [Reference Citation Analysis]
3 Stabenau KA, Samuels TL, Lam TK, Mathison AJ, Wells C, Altman KW, Battle MA, Johnston N. Pepsinogen/Proton Pump Co-Expression in Barrett's Esophageal Cells Induces Cancer-Associated Changes. Laryngoscope 2022. [PMID: 35315085 DOI: 10.1002/lary.30109] [Reference Citation Analysis]
4 Degroote H, Lefere S, Vandierendonck A, Vanderborght B, Meese T, Van Nieuwerburgh F, Verhelst X, Geerts A, Van Vlierberghe H, Devisscher L. Characterization of the inflammatory microenvironment and hepatic macrophage subsets in experimental hepatocellular carcinoma models. Oncotarget 2021;12:562-77. [PMID: 33796224 DOI: 10.18632/oncotarget.27906] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
5 Xu W, Chen Z, Liu G, Dai Y, Xu X, Ma D, Liu L. Identification of a Potential PPAR-Related Multigene Signature Predicting Prognosis of Patients with Hepatocellular Carcinoma. PPAR Res 2021;2021:6642939. [PMID: 33777129 DOI: 10.1155/2021/6642939] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Malik A, Thanekar U, Amarachintha S, Mourya R, Nalluri S, Bondoc A, Shivakumar P. "Complimenting the Complement": Mechanistic Insights and Opportunities for Therapeutics in Hepatocellular Carcinoma. Front Oncol 2020;10:627701. [PMID: 33718121 DOI: 10.3389/fonc.2020.627701] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
7 Lu S, Dai M, Hu X, Yi H, Zhang Y. A new survival model based on ion channel genes for prognostic prediction in hepatocellular carcinoma. Genomics 2021;113:171-82. [PMID: 33340691 DOI: 10.1016/j.ygeno.2020.12.028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]